UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016213 |
|---|---|
| Receipt number | R000018742 |
| Scientific Title | A feasibility study of dose-dense epirubicin and cyclophosphamide for primary breast cancer in neoadjuvant and adjuvant setting |
| Date of disclosure of the study information | 2015/01/28 |
| Last modified on | 2017/12/19 09:47:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/01/14 17:51:59 | ||
| 2 | Update | 2015/02/27 09:48:11 | Public title Public title |
|
| 3 | Update | 2015/02/27 09:49:45 | Narrative objectives1 Narrative objectives1 |
|
| 4 | Update | 2015/02/27 09:50:59 | Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2015/03/11 11:07:06 | Recruitment status Anticipated trial start date |
|
| 6 | Update | 2015/07/31 16:19:29 | Condition Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2015/07/31 16:21:43 | Key secondary outcomes Key secondary outcomes |
|
| 8 | Update | 2016/07/11 16:12:35 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 9 | Update | 2016/07/11 16:14:56 | Recruitment status |
|
| 10 | Update | 2017/12/19 09:47:40 | Recruitment status Publication of results URL related to results and publications |
